The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
about
sameAs
Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini ReviewUnderutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expressionIs ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritisGut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitolA 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.Valdecoxib for the management of chronic and acute pain.Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia.GERD prevalence in migraine patients and the implication for acute migraine treatment.Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers.Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial.Myths and facts in the use of anti-inflammatory drugs.The pharmacology of esomeprazole and its role in gastric acid related diseases.Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: a meta-analysis.Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.Cost of arthritis: a systematic review of methodologies used for direct costs.Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.A 6-year trend of the healthcare costs of arthritis in a population-based cohort of older women.Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.Clinically relevant pain relief with an ibuprofen-releasing foam dressing: results from a randomized, controlled, double-blind clinical trial in exuding, painful venous leg ulcers.The effects of a psychological intervention directed at optimizing immune function: study protocol for a randomized controlled trial.The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.Gastrointestinal bleed induced by a fixed dose combination of rabeprazole and diclofenac sodium.A comparison of transdermal over-the-counter lidocaine 3.6% menthol 1.25%, Rx lidocaine 5% and placebo for back pain and arthritis.Effects of periarticular injection on analgesic effects and NSAID use in total knee arthroplasty and total hip arthroplasty.Protective multimodal analgesia with etoricoxib and spinal anesthesia in inguinal hernia repair: a randomized controlled trial.Investigation of chronic efficacy and safety profile of two potential anti-inflammatory bipyrazole-based compounds in experimental animals.Microwave Assisted Synthesis, Pharmacological Activities, and Molecular Docking Studies of Ethyl 2-[2-Substituted-4-(Thiophenyl) Thiazolyl] Acetates.Non-steroidal anti-inflammatory drug use and risk of venous thromboembolismNonsteroidal Antiinflammatory Drug Use and Cardiovascular Risks After Coronary Stent ImplantationNewer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis
P2860
Q24634894-EB4824A3-200F-466B-B5CD-F224D9380CC5Q24816911-115E4A0E-89C0-4374-884F-1811706A4522Q28196811-0A9F9B6E-9A65-42C4-9363-223EB6A082D4Q28201393-630FE0A8-8576-4132-89E5-EFC518B69329Q28218359-671E528F-36EF-4D40-9E4B-CD813341D528Q28245954-83ED67AA-5511-4A12-BC4E-43F410F99CAEQ33367787-3BAA33DC-8805-4B6D-9A7F-12264B367B9EQ34557067-86A66285-8249-49DB-81C8-042C9121D1D2Q34606022-7FE4D0AA-1EEA-41E4-A8F6-7CD673011729Q35873855-A793CE2A-CD94-476F-82AF-5BA6038BB080Q36259843-C48DE482-1EF0-4C83-B4A7-651A7D73C805Q36808048-4B54F5DB-CDE9-4ABC-804E-7FB63E9B7ED7Q36830115-F3CF5630-0B0A-4FE9-A4AD-2EB58378B3FBQ37400399-6F2E1FC4-30D6-42B0-B91A-A6567643B6D1Q37476911-6F90AA3D-1CA3-4F24-B795-4AA24929FFE7Q37552951-C203796D-EA92-4259-87E9-B4591B8A3C67Q37661099-F43BBF8E-1013-4F0F-ADA3-20EFDF986EC4Q38068081-A8307511-6087-4BE0-9B99-F30652839C27Q38126948-B5AA736F-BBFC-49DA-942C-3ADBC13D32F3Q38652998-312BF817-C076-452E-847F-16C45D066579Q38850732-F4EEEBFE-F6A7-4A95-97E1-39404521FB58Q38947437-BF5086E0-F525-463D-9A5D-15843F94F402Q39208801-6A25A329-B93D-41AB-A71F-3D936828C793Q39239208-B45F97F4-1000-4056-B4E1-1AB1785CEBFCQ40197195-BB776E13-F861-4F2D-8934-BC6D02797583Q41858880-BEA411FE-A87B-44E4-919A-D9B49CC78E53Q42916631-0AA6E431-9FDC-4523-8E9D-705E04A4843FQ46271610-74C221AA-2BCE-416D-B3C8-4C31DE1AF098Q47145011-E09C823D-282E-4148-BC67-48A63C732F2EQ47301726-BC5C1EB6-E106-4DED-BA75-2852CBB6AF65Q52584469-56E56494-9C95-4948-B2F9-9204CBAB68A4Q54996798-FF4F5911-660E-403F-ACDA-A63DF1AA14CAQ57300335-7AB20969-F53A-4CAA-AC4F-A7C80CAA4F38Q57300338-A8C0F35E-72BF-449D-A1B3-9A13ECBC0CC1Q57300657-F77E8A24-B56C-43A8-9128-31F3782A1A71
P2860
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@ast
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@en
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@nl
type
label
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@ast
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@en
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@nl
prefLabel
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@ast
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@en
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@nl
P356
P1476
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
@en
P2093
Loren Laine
P356
10.1053/SARH.2002.37217
P407
P433
P577
2002-12-01T00:00:00Z